SARAH TISSER: Open Payments
NPI 1417621541 · NORTHBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 42 payments from 15 companies in 2025. Trend: 2023 $713 · 2024 $803 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $176 |
| Axsome Therapeutics, Inc. | 5 | $174 |
| Supernus Pharmaceuticals, Inc. | 4 | $164 |
| Otsuka America Pharmaceutical, Inc. | 5 | $122 |
| HARMONY BIOSCIENCES LLC | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Tris Pharma Inc | 3 | $54 |
| Lundbeck LLC | 2 | $50 |
| Alkermes, Inc. | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
Products named: REXULTI, Qelbree, Auvelity, UBRELVY, WAKIX, CAPLYTA, Dyanavel XR, ARISTADA.
Industry payments across IL — which companies pay providers there.
